Charles River Laboratories
409 hedge funds and large institutions have $6.78B invested in Charles River Laboratories in 2019 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 130 increasing their positions, 162 reducing their positions, and 50 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
31% more capital invested
Capital invested by funds: $5.16B → $6.78B (+$1.62B)
10% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 50
1.8% more ownership
Funds ownership: 95.09% → 96.89% (+1.8%)
0% more funds holding
Funds holding: 407 → 409 (+2)
20% less repeat investments, than reductions
Existing positions increased: 130 | Existing positions reduced: 162
59% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $45.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$58.7M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$41.6M |
| 3 |
SC
Sculptor Capital
New York
|
+$40.1M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$34.5M |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$31.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$56.1M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$35.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$34.8M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$22.3M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$21.5M |
CRL Hedge Fund Activity: Q1 2019 in Review
409 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2019, worth a combined $6.78B — up 31% from $5.16B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new CRL positions and 50 closed out — a net gain of 5 holders — while 130 added to existing stakes and 162 trimmed.
The largest buyer was Millennium Management, adding an estimated $58.7M. The largest seller was Wells Fargo, cutting an estimated $56.1M.
- 409 institutional investors held Charles River Laboratories (CRL) as of Q1 2019, up from 407 in Q4 2018.
- Funds reported $6.78B of Charles River Laboratories stock for Q1 2019, up 31% quarter-over-quarter.
- 55 funds opened new Charles River Laboratories positions in Q1 2019 and 50 closed out, a net change of +5 holders.
- The largest Charles River Laboratories buyer in Q1 2019 was Millennium Management, an estimated $58.7M added.
- The largest Charles River Laboratories seller in Q1 2019 was Wells Fargo, an estimated $56.1M sold.
Based on aggregated 13F filings for Q1 2019.